Found: 7
Select item for more details and to access through your institution.
SGLT2 inhibitor improves the prognosis of patients with coronary heart disease and prevents in-stent restenosis.
- Published in:
- Frontiers in Cardiovascular Medicine, 2024, p. 1, doi. 10.3389/fcvm.2023.1280547
- By:
- Publication type:
- Article
Delayed PCI is not beneficial for STEMI patients with impaired renal function: a retrospective cohort study.
- Published in:
- BMC Cardiovascular Disorders, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12872-023-03271-2
- By:
- Publication type:
- Article
Bibliometric Study of Sodium Glucose Cotransporter 2 Inhibitors in Cardiovascular Research.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.561494
- By:
- Publication type:
- Article
CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.848310
- By:
- Publication type:
- Article
Optimal dose of physical exercise for preventing cardiac and renal dysfunction, data from National Health and Nutrition Examination Surveys survey.
- Published in:
- European Journal of Preventive Cardiology, 2022, v. 29, n. 12, p. 1703, doi. 10.1093/eurjpc/zwac096
- By:
- Publication type:
- Article
Bioinformatics exploration of potential common therapeutic targets for systemic and pulmonary arterial hypertension-induced myocardial hypertrophy.
- Published in:
- Acta Biochimica et Biophysica Sinica, 2023, v. 55, n. 5, p. 831, doi. 10.3724/abbs.2023071
- By:
- Publication type:
- Article
Decoding HiPSC-CM's Response to SARS-CoV-2: mapping the molecular landscape of cardiac injury.
- Published in:
- BMC Genomics, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12864-024-10194-5
- By:
- Publication type:
- Article